Wagner Klaus W. 4
4 · Inhibrx, Inc. · Filed Jan 19, 2021
Insider Transaction Report
Form 4
Inhibrx, Inc.INBX
Wagner Klaus W.
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
[F1]2021-01-15+120,000→ 120,000 totalExercise: $33.63Exp: 2031-01-15→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1](1) Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on January 15, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
Signature
/s/ Kelly D. Deck, attorney-in-fact|2021-01-19